Home » Topics » BioWorld Science

BioWorld Science
RSS

5-HT1A agonist for cognition disorders disclosed

June 21, 1996

Alzheimer's beta-protein inhibition method described

June 21, 1996

Cholinergic agonists claimed by Lilly

June 21, 1996

Anergen's MS-AnergiX enters phase I for MS

June 21, 1996

Agents for multiple sclerosis disclosed

June 21, 1996

Discovery Therapeutic's N-0923 trial results to be presented

June 21, 1996

Peptides resembling h-MBP claimed

June 21, 1996

COMT inhibitor disclosed by Roche

June 21, 1996

BioKePharm and Gruppo Marcucci to merge

June 21, 1996

Taro's anticonvulsant drug undergoes development

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...